Company profile
ReFlow Therapeutics company profile
ReFlow is pioneering in a novel approach for real-time diagnosis and treatment of the no-reflow phenomenon in acute heart attack and later heart failure patients. ReFlow’s medical system will allow for overcoming micro-vascular obstruction (MVO) and blockage in the very small blood supply vessels within the affected heart muscle in heart attack patients. ReFlow completed its proof-of-concept trials at the University Hospital of Zürich and filed provisional patent applications in Europe and the United States.
Business identity
- Contact email
- [email protected]
- Phone number
- +41415445555
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2016-01-01, Year
Headquarters
- Headquarters
- Baar, Zug, Switzerland
- Postal code
- 6340
- Country code
- CH
- Continent
- Europe